OFIX (Orthofix Medical) EBITDA per Share: $0.47 (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OFIX Orthofix Medical Inc OFIX
57 GF Score
Price $9.91
GF Value $13.93
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Orthofix Medical EBITDA per Share?

Orthofix Medical OFIX -1.00% 57 EBITDA per Share is $0.47 as of Jun. 2026. GuruFocus rates OFIX with a GF Score™ of 57/100 and a GF Value™ of $13.93 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 690 Medical Devices & Instruments companies, Orthofix Medical ranks worse than 91.88% on this metric.

Orthofix Medical's EBITDA per Share for the three months ended in Jun. 2026 was $0.13. Its EBITDA per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.47.

During the past 12 months, the average EBITDA per Share Growth Rate of Orthofix Medical was 406.50% per year. During the past 3 years, the average EBITDA per Share Growth Rate was -31.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Orthofix Medical's EBITDA per Share or its related term are showing as below:

OFIX' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -70   Med: 2.95   Max: 112
Current: -31.5

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Orthofix Medical was 112.00% per year. The lowest was -70.00% per year. And the median was 2.95% per year.

OFIX's 3-Year EBITDA Growth Rate is ranked worse than
91.88% of 690 companies
in the Medical Devices & Instruments industry
Industry Median: 8.2 vs OFIX: -31.50

Orthofix Medical's EBITDA for the three months ended in Jun. 2026 was $5.4 Mil.

During the past 12 months, the average EBITDA Growth Rate of Orthofix Medical was 421.00% per year. During the past 3 years, the average EBITDA Growth Rate was -14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Orthofix Medical was 116.20% per year. The lowest was -69.80% per year. And the median was 3.90% per year.


Orthofix Medical  (NAS:OFIX) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Orthofix Medical EBITDA per Share Related Terms


Orthofix Medical EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Orthofix Medical's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orthofix Medical EBITDA per Share Chart

Orthofix Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.09 0.78 -2.16 -0.48 0.25

Orthofix Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 -0.08 0.43 -0.02 0.13
OFIX
57GF Score
Orthofix Medical Inc OFIX
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orthofix Medical EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Orthofix Medical's EBITDA per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA per Share(A: Dec. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=9.933/39.602
=0.25

Orthofix Medical's EBITDA per Share for the quarter that ended in Jun. 2026 is calculated as

EBITDA per Share(Q: Jun. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=5.449/40.906
=0.13

EBITDA per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of $0.47 mean?
Orthofix Medical (OFIX) has a EBITDA per Share of $0.47 as of Jun. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Orthofix Medical and its competitors. According to the industry distribution chart, Orthofix Medical ranks #634 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 91.9%.
Is Orthofix Medical's EBITDA per Share too high?
Orthofix Medical's current EBITDA per Share is $0.47. The Medical Devices & Instruments industry median EBITDA per Share is 8.20. Orthofix Medical's value of $0.47 is 94.3% below this industry median. Based on the distribution chart, Orthofix Medical ranks #634 out of 690 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Orthofix Medical has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Orthofix Medical's EBITDA per Share compare to VMD and VREX?
According to the Medical Devices & Instruments industry distribution chart, Orthofix Medical ranks #634 out of 690 companies for EBITDA per Share. This places Orthofix Medical in the lower half of its industry. The industry median EBITDA per Share is 8.20. Orthofix Medical's value of $0.47 is 94.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Medical Devices & Instruments company?
The median EBITDA per Share among Medical Devices & Instruments companies is 8.20, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orthofix Medical's current EBITDA per Share of $0.47 is 94.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Orthofix Medical and its competitors. For the Medical Devices & Instruments industry, the median EBITDA per Share is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orthofix Medical's current EBITDA per Share is $0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orthofix Medical stock overvalued right now?
Based on GuruFocus' analysis, Orthofix Medical (OFIX) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.93, compared to a current price of $9.91 — trading 28.9% below its estimated fair value. The current EBITDA per Share is $0.47 and 94.3% below the Medical Devices & Instruments industry median of 8.20. Orthofix Medical's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Orthofix Medical (OFIX), the current EBITDA per Share is $0.47 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orthofix Medical (OFIX) Overvalued in 2026?

Based on GuruFocus' analysis, Orthofix Medical stock appears to be undervalued. The current stock price of $9.91 is trading 28.9% below its estimated GF Value™ of $13.93. GuruFocus considers Orthofix Medical to be Modestly Undervalued.

Key valuation signals for OFIX:

  • EBITDA per Share: $0.47
  • GF Value™: $13.93 vs. price of $9.91 (28.9% below fair value)
  • GF Score™: 57/100 with 6 warning signs
  • Industry Position: 94.3% below the Medical Devices & Instruments median (#634 of 690)

No single metric tells the full story. See the OFIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Orthofix Medical Business Description

Other Exchanges OM2:Germany
Address 3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
57GF Score

Get the complete analysis for OFIX

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.91
Price
$13.93
GF Value